ELV Stock Overview
Elevance Health Inc. operates as a health benefits company.
Elevance Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$483.97|
|52 Week High||US$533.68|
|52 Week Low||US$355.43|
|1 Month Change||-0.066%|
|3 Month Change||-0.70%|
|1 Year Change||28.25%|
|3 Year Change||68.69%|
|5 Year Change||150.78%|
|Change since IPO||2,266.60%|
Recent News & Updates
Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Elevance Health declares $1.28 dividend
Elevance Health (NYSE:ELV) declares $1.28/share quarterly dividend, in line with previous. Forward yield 1.03% Payable Sept. 23; for shareholders of record Sept. 9; ex-div Sept. 8. See ELV Dividend Scorecard, Yield Chart, & Dividend Growth.
Do Elevance Health's (NYSE:ELV) Earnings Warrant Your Attention?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
|ELV||US Healthcare||US Market|
Return vs Industry: ELV exceeded the US Healthcare industry which returned 13.5% over the past year.
Return vs Market: ELV exceeded the US Market which returned -13% over the past year.
|ELV Average Weekly Movement||4.5%|
|Healthcare Industry Average Movement||9.0%|
|Market Average Movement||7.9%|
|10% most volatile stocks in US Market||17.2%|
|10% least volatile stocks in US Market||3.2%|
Stable Share Price: ELV is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ELV's weekly volatility (4%) has been stable over the past year.
About the Company
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Elevance Health Fundamentals Summary
|ELV fundamental statistics|
Is ELV overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ELV income statement (TTM)|
|Cost of Revenue||US$111.18b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||25.43|
|Net Profit Margin||4.09%|
How did ELV perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Does ELV pay a reliable dividends?See ELV dividend history and benchmarks
|Elevance Health dividend dates|
|Ex Dividend Date||Sep 08 2022|
|Dividend Pay Date||Sep 23 2022|
|Days until Ex dividend||29 days|
|Days until Dividend pay date||44 days|
Does ELV pay a reliable dividends?See ELV dividend history and benchmarks
Is ELV undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ELV?
Other financial metrics that can be useful for relative valuation.
|What is ELV's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does ELV's PE Ratio compare to its peers?
|ELV PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
UNH UnitedHealth Group
MOH Molina Healthcare
ELV Elevance Health
Price-To-Earnings vs Peers: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (25.4x).
Price to Earnings Ratio vs Industry
How does ELV's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the US Healthcare industry average (20.3x)
Price to Earnings Ratio vs Fair Ratio
What is ELV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||19x|
|Fair PE Ratio||38.5x|
Price-To-Earnings vs Fair Ratio: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (38.5x).
Share Price vs Fair Value
What is the Fair Price of ELV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ELV ($483.97) is trading below our estimate of fair value ($804.73)
Significantly Below Fair Value: ELV is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Elevance Health forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELV's forecast earnings growth (10.7% per year) is above the savings rate (1.9%).
Earnings vs Market: ELV's earnings (10.7% per year) are forecast to grow slower than the US market (14.6% per year).
High Growth Earnings: ELV's earnings are forecast to grow, but not significantly.
Revenue vs Market: ELV's revenue (6.9% per year) is forecast to grow slower than the US market (7.9% per year).
High Growth Revenue: ELV's revenue (6.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ELV's Return on Equity is forecast to be low in 3 years time (19.1%).
Discover growth companies
How has Elevance Health performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ELV has high quality earnings.
Growing Profit Margin: ELV's current net profit margins (4.1%) are higher than last year (3.3%).
Past Earnings Growth Analysis
Earnings Trend: ELV's earnings have grown by 11.3% per year over the past 5 years.
Accelerating Growth: ELV's earnings growth over the past year (44.3%) exceeds its 5-year average (11.3% per year).
Earnings vs Industry: ELV earnings growth over the past year (44.3%) exceeded the Healthcare industry 7.7%.
Return on Equity
High ROE: ELV's Return on Equity (16.9%) is considered low.
Discover strong past performing companies
How is Elevance Health's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: ELV's short term assets ($53.7B) exceed its short term liabilities ($39.3B).
Long Term Liabilities: ELV's short term assets ($53.7B) exceed its long term liabilities ($25.7B).
Debt to Equity History and Analysis
Debt Level: ELV has more cash than its total debt.
Reducing Debt: ELV's debt to equity ratio has reduced from 66.2% to 65.8% over the past 5 years.
Debt Coverage: ELV's debt is well covered by operating cash flow (38.9%).
Interest Coverage: ELV's interest payments on its debt are well covered by EBIT (10.9x coverage).
Discover healthy companies
What is Elevance Health current dividend yield, its reliability and sustainability?
Dividend Score 4/6
Cash Flow Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: ELV's dividend (1.06%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.52%).
High Dividend: ELV's dividend (1.06%) is low compared to the top 25% of dividend payers in the US market (4.08%).
Stability and Growth of Payments
Stable Dividend: ELV's dividends per share have been stable in the past 10 years.
Growing Dividend: ELV's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (19.1%), ELV's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (15.3%), ELV's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gail Boudreaux (61 yo)
Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Elevance Health Inc. (formerly kn...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD19.35M) is above average for companies of similar size in the US market ($USD12.91M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
Experienced Management: ELV's management team is seasoned and experienced (6.2 years average tenure).
Experienced Board: ELV's board of directors are considered experienced (9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ELV insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Elevance Health Inc.'s employee growth, exchange listings and data sources
- Name: Elevance Health Inc.
- Ticker: ELV
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Implied Market Cap: US$116.153b
- Shares outstanding: 240.00m
- Website: https://www.elevancehealth.com
Number of Employees
- Elevance Health Inc.
- 220 Virginia Avenue
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/09 00:00|
|End of Day Share Price||2022/08/09 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.